ArriVent BioPharma

AVBPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.466 B

$29.74 +2.91%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$166.3M

Loss-making

Shares outstanding

49,307,729

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#129InnovivaINVA$1.52B
#130Ascentage Pharma Group InternationalAAPG$1.48B
#131ArriVent BioPharmaAVBP$1.47B
#132Bicara TherapeuticsBCAX$1.46B
#133Ultragenyx PharmaceuticalRARE$1.44B

What if ArriVent BioPharma were worth as much as…

Open the what-if tool →

Gold $30.3T

$613,981.92

Per share 20,645× higher

Bitcoin $1.72T

$34,878.99

Per share 1,173× higher

Nvidia $5.48T

$111,135.88

Per share 3,737× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for ArriVent BioPharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.